ArticleApplied biochemistry and biotechnology2024

In Silico Repurposing of a Novel Inhibitor (drug) of EGFR and VEGFR-2 Kinases of Cancer by Pharmacokinetics, Toxicity, Molecular Docking, and Molecular Dynamics Simulation.

Mona H Ibraheim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.